INBS — Intelligent Bio Solutions Share News
0.000.00%
- $5.27m
- $1.06m
- $4.22m
Brief: Intelligent Bio Solutions Initiates Clinical Study Supporting FDA Clearance And Planned US Market Entry
Intelligent Bio Solutions Q3 revenue rises 46%, gross margin tops 50%
Intelligent Bio Solutions rise after clearing security tests ahead of FDA filing
Brief: Intelligent Bio Solutions Completes Clinical Cut-Off Study
Brief: Intelligent Bio Solutions Announces Delivery In Partnership With Syrma Johari
Brief: Intelligent Bio Solutions Partners With Bouygues UK
Brief: Intelligent Bio Solutions Reports Record Fiscal Second Quarter Revenue Growth Of 48% With Reader Sales Surging 104% Year-Over-Year
NASDAQ RESUMED AT 09:35 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM
Brief: Intelligent Bio Solutions Announces $10 Million Private Placement Priced At-The-Market Under Nasdaq Rules
NASDAQ RESUMED AT 10:12 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:07 AM
NASDAQ RESUMED AT 09:56 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:51 AM
NASDAQ RESUMED AT 09:41 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:31 AM
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM